CJC-1295 for Adolescent Girls (Ages 12 to 17): What You Need to Know About Transitioning to Adult Care
CJC-1295 use in adolescent girls aged 12 to 17 is not FDA-approved. Learn what transition to adult care means, why this matters for girls, and safer alternatives.
Read clinical review